These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 27362232)

  • 21. Structural and Functional Studies on the Marburg Virus GP2 Fusion Loop.
    Liu N; Tao Y; Brenowitz MD; Girvin ME; Lai JR
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S146-53. PubMed ID: 25786917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway.
    Spence JS; Krause TB; Mittler E; Jangra RK; Chandran K
    mBio; 2016 Feb; 7(1):e01857-15. PubMed ID: 26861015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection.
    Nelson EA; Dyall J; Hoenen T; Barnes AB; Zhou H; Liang JY; Michelotti J; Dewey WH; DeWald LE; Bennett RS; Morris PJ; Guha R; Klumpp-Thomas C; McKnight C; Chen YC; Xu X; Wang A; Hughes E; Martin S; Thomas C; Jahrling PB; Hensley LE; Olinger GG; White JM
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005540. PubMed ID: 28403145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.
    O'Hearn A; Wang M; Cheng H; Lear-Rooney CM; Koning K; Rumschlag-Booms E; Varhegyi E; Olinger G; Rong L
    J Virol; 2015 May; 89(10):5441-9. PubMed ID: 25741008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change.
    Brecher M; Schornberg KL; Delos SE; Fusco ML; Saphire EO; White JM
    J Virol; 2012 Jan; 86(1):364-72. PubMed ID: 22031933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.
    Côté M; Misasi J; Ren T; Bruchez A; Lee K; Filone CM; Hensley L; Li Q; Ory D; Chandran K; Cunningham J
    Nature; 2011 Aug; 477(7364):344-8. PubMed ID: 21866101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
    Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
    Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry.
    Fels JM; Spence JS; Bortz RH; Bornholdt ZA; Chandran K
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological Characterization of Conserved Residues within the Cytoplasmic Tail of the Pichinde Arenaviral Glycoprotein Subunit 2 (GP2).
    Shao J; Huang Q; Liu X; Di D; Dileepan M; Brisse M; Ly H; Liang Y
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Filovirus entry: a novelty in the viral fusion world.
    Hunt CL; Lennemann NJ; Maury W
    Viruses; 2012 Feb; 4(2):258-75. PubMed ID: 22470835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway.
    Ruedas JB; Arnold CE; Palacios G; Connor JH
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional importance of the coiled-coil of the Ebola virus glycoprotein.
    Watanabe S; Takada A; Watanabe T; Ito H; Kida H; Kawaoka Y
    J Virol; 2000 Nov; 74(21):10194-201. PubMed ID: 11024148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Filovirus proteins for antiviral drug discovery: A structure/function analysis of surface glycoproteins and virus entry.
    Martin B; Hoenen T; Canard B; Decroly E
    Antiviral Res; 2016 Nov; 135():1-14. PubMed ID: 27640102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
    Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
    Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution.
    Malashkevich VN; Schneider BJ; McNally ML; Milhollen MA; Pang JX; Kim PS
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2662-7. PubMed ID: 10077567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor.
    Lee JE; Fusco ML; Hessell AJ; Oswald WB; Burton DR; Saphire EO
    Nature; 2008 Jul; 454(7201):177-82. PubMed ID: 18615077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of the Ebola virus glycoprotein spike within the virion envelope at 11 Å resolution.
    Beniac DR; Booth TF
    Sci Rep; 2017 Apr; 7():46374. PubMed ID: 28397863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designed protein mimics of the Ebola virus glycoprotein GP2 α-helical bundle: stability and pH effects.
    Harrison JS; Higgins CD; Chandran K; Lai JR
    Protein Sci; 2011 Sep; 20(9):1587-96. PubMed ID: 21739501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity.
    Hood CL; Abraham J; Boyington JC; Leung K; Kwong PD; Nabel GJ
    J Virol; 2010 Mar; 84(6):2972-82. PubMed ID: 20053739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry.
    Hoffmann M; Crone L; Dietzel E; Paijo J; González-Hernández M; Nehlmeier I; Kalinke U; Becker S; Pöhlmann S
    J Virol; 2017 May; 91(9):. PubMed ID: 28228590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.